Send feedback

HOOK2 p.His488Gln

c.1464C>G · rs897804 · VCV1225367

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.1098 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 40.9%, mid) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
scoliosis, isolated, susceptibility to, 1

Computational evidence

Protein change
AlphaMissense0.1098likely benign
REVEL0.058moderately benign-leaning
SaProtLLR -3.83tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 3.9GERP -0.001, phastCons 1
Regional constrainto/e 1.08unconstrained · MANE · 5,167 bp · p 0.12 · regional, not allelic
Overall
CADD20.1PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 40.9% Middle Eastern · 2,349/5,740 alleles
Filtering AF 40.1% ClinGen BA1/BS1 input FAF95, joint · FAF99 40%
Overall 36.3% 580,517/1,599,928 alleles · common exomes 536,196/1,447,762 · genomes 44,321/152,166 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 46.3% 2
Middle Easterngrpmax 40.9% 2
European (non-Finnish) 40.2% 2
Finnishnot grpmax-eligible 37.1% 3
Amishnot grpmax-eligible 37.1% 3
Remaining individualsnot grpmax-eligible 35% 3
Admixed American 25.8% 4
East Asian 23.2% 4
South Asian 20.2% 5
African / African-American 7.19% 14

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
HOOK2
Protein
p.His488Gln
Coding
c.1464C>G
MANE Select
NM_013312
dbSNP
rs897804
Type
single nucleotide variant
Location
chr19:12766150 (GRCh38)
Gene constraint
LOEUF 1.16 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 82.81
Residue 488
a UniProt-annotated variant site (in); the 'sufficient for interaction with microtubules' region
Full HOOK2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/hook2-p-his488gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown